Southeast Asia Pharma and Healthcare Sector Report 2020/2024An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company Date: August 2020
Available in: English
Healthcare remains in inadequate supply throughout most of the SEA region. The shortage is especially evident in healthcare human resources; for instance, apart from Malaysia and China, all the countries in the SEA region have fewer than 1 physician per 1,000 population, compared with 2.4 physicians per 1,000 in Japan, and 2.6 physicians per 1,000 in the USA. The Philippines, which has the highest proportion of nurses and midwives per 1,000 population at 4.9, has only a third of the number of nurses and midwives per capita compared with the USA, at 14.5 nurses and midwives per 1,000.
This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Southeast Asia . EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
- Understand the key elements at play in the healthcare and pharmaceutical sector in Southeast Asia
- Access forecasts for growth in the sector
- View key data on healthcare spending and health insurance in Southeast Asia
- Crystallise the forces both driving and restraining this sector in Southeast Asia
- Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
- Gain an understanding of the regulatory environment for the sector in Southeast Asia
- Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).
See below for a complete table of report contents: